Methionine- and choline-deficient diet induces hepatic changes characteristic of non-alcoholic steatohepatitis;Dieta deficiente em metionina e colina induz mudanças hepáticas características de esteatohepatite não-alcoólica

Arquivos de Gastroenterologia

Volumn 48, Issue 1, 2011, Pages 72-79

  Marcolin, Éder ^a,c   Forgiarini, Luiz Felipe ^b   Tieppo, Juliana ^c   Dias, Alexandre Simões ^b,c   de Freitas, Luiz Antonio Rodrigues ^d   Marroni, Norma Possa ^e  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^b IPA   (Brazil)

^c HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

^d INSTITUTO OSWALDO CRUZ   (Brazil)

^e UNIVERSIDADE LUTERANA DO BRASIL   (Brazil)

Author keywords

Choline deficiency; Fatty liver; Methionine; Mice; Oxidative stress

Indexed keywords

CHOLINE; GLUTATHIONE; HIGH DENSITY LIPOPROTEIN; METHIONINE; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOCHEMISTRY; BLOOD SAMPLING; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIET; ENZYME ACTIVITY; EXSANGUINATION; GLUCOSE BLOOD LEVEL; HISTOPATHOLOGY; LAPAROTOMY; LIPID PEROXIDATION; LIVER RESECTION; MALE; MOUSE; NONALCOHOLIC FATTY LIVER; NONHUMAN;

EID: 79956332924     PISSN: 00042803     EISSN: 16784219     Source Type: Journal    
DOI: 10.1590/s0004-28032011000100015     Document Type: Article

References (54)

1. Albright CD, Liu R, Bethea TC, Da Costa KA, Salganik RI, Zeisel SH. Choline deficiency induces apoptosis in SV40-immortalized CWSV-1 rat hepatocytes in culture. Faseb J. 1996;10:510-6.
2. Albright CD, Zeisel SH, Salganik RI. Choline deficiency induces apoptosis and decreases the number of eosinophilic preneoplastic foci in the liver of OXYS rats. Pathobiology. 1998;66:71-6.
3. American Veterinary Medical Association-AVMA. AVMA guidelines on euthanasia (Formerly Report of the AVMA Panel on Euthanasia) [Internet]. Schaumburg, IL, 2007. Available from: http://www.avma.org/issues/animal_welfare/euthanasia.pdf
4. Ames BN. DNA damage from micronutrient deficiencies is likely to be a major cause of cancer. Mutat Res. 2001;475:7-20.
5. Bacon BR, Farahvash MJ, Janney CG, Neuschwander-Tetri BA. Nonalcoholic steatohepatitis: an explanded clinical entity. Gastroenterology. 1994;107:1103-9.
6. Banni S, Corongiu FP, Dessi MA, Iannone A, Lombardi B, Tomasi A, Vannini V. Free radicals and lipid peroxidation in liver of rats kept on a diet devoid of choline. Free Radic Res Commun. 1989;7:233-40.
7. Barak AJ, Beckenhauer HC. The influence of ethanol on hepatic transmethylation. Alcohol Alcohol. 1988;23:73-7.
8. Berson A, De Beco V, Letteron P, Robin MA, Moreau C, El Kahwaji J, Verthier N, Feldmann G, Fromenty B, Pessayre D. Steatohepatitis-inducing drugs cause mitochondrial dysfunction and lipid peroxidation in rat hepatocytes. Gastroenterology. 1998;114:764-74.
9. Beutler E, Duron O, Kelly BM. Improved method for determination of blood glutathione. J Lab Clin Med. 1963;61:882-8.
10. Boveris A, Chance B. The mitochondrial generation of hydrogen peroxide: general propertiesand effect of hyperbaric oxygen. Biochem J. 1973;134:707-16.
11. Bremer J, Greenberg DM. Biosynthesis of choline in vitro. Biochim Biophys Acta. 1960;37:173-5.
12. Brunt E. Pathology of nonalcoholic steatohepatitis. Hepatol Res. 2005;33: 68-71.
13. Brunt EM, Janney CG, Di Bisceglie AM, Neuschwander-Tetri BA, Bacon BR. Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions. Am J Gastroenterol. 1999;94:2467-74.
14. Brunt EM. Pathology of nonalcoholic steatohepatitis. Hepatol Res. 2005;33:68-71.
15. Brunt EM, Tiniakos DG. Pathological features of NASH. Front Biosci. 2005;10:1475-84.
16. Buege J, Aust S. Microssomal lipid peroxidation. Methods Enzimol. 1978;52:302-10.
17. Caldwell SH, Oelsner DH, Iezzoni JC, Hepenheide EE, Battle EH, Driscoll CJ. Cryptogenic cirrhosis: clinical characterization and risk factors for underlying disease. Hepatology. 1999;29:664-9.
18. Carleton MD, Musser GG. Order Rodentia. In: Wilson DE, Reeder DM, editors. Mammal species of the world: a taxonomic and geographic reference. 3rd ed. Baltimore: Johns Hopkins University Press; 2005. v.2, p.745-52.
19. Chitturi S, Farrel GC. Etiopathogenesis of nonalcoholic steatohepatitis. Semin Liver Dis. 2001;21:27-41.
20. Clark JM, Brancati FL, Diehl AM. Nonalcoholic fatty liver disease. Gastroenterology. 2002;122:1649-57.
21. Engel RW, Salmon WD. Improved diets for nutritional and pathologic studies of choline deficiency in rats. J Nutr. 1941;22:109-21.
22. Eriksson S, Eriksson KF, Bondesson L. Nonalcoholic steatohepatitis in obesity: a reversible condition. Acta Med Scand. 1986;220:83-8.
23. Farrel GC. Drugs and steatohepatitis. Semin Liver Dis. 2002;22:185-94.
24. Fast DG, Vance DE. Nascent VLDL phospholipid composition is altered when phosphatidylcholine biosynthesis is inhibited: evidence for a novel mechanism that regulates VLDL secretion. Biochim Biophys Acta. 1995;1258:159-68.
25. Freitas L, Cotrim H. Atlas histológico de esteato-hepatite não alcoólica-NASH. Salvador: Zambon; 2006.
26. Frontiera MS, Stabler SP, Kolhousea JF, Allen RH. Regulation of methionine metabolism: effects of nitrous oxide and excess dietary methionine. J Nutrion Biochem. 1993;5:28-38.
27. George J, Pera N, Phung N, Leclercq I, Yun Hou J, Farrell G. Lipid peroxidation, stellate cell activation and hepatic fibrogenesis in a rat model of chronic steatohepatitis. J Hepatol. 2003;39:756-64.
28. Harrison S, Neuschwander-Tetri B. Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis. Clin Liver Dis. 2004;8:861-79.
29. Ip E, Farrell GC, Robertson G, Hall P, Kirsch R, Leclercq I. Central role of PPARalpha-dependent hepatic lipid turnover in dietary steatohepatitis in mice. Hepatology. 2003;38:123-32.
30. Kakuma T, Lee Y, Higa M, Wang Z, Pan W, Shimomura I, Unger RH. Leptin, troglitazone, and the expression of sterol regulatory element binding proteins in liver and pancreatic islets. Proc Natl Acad Sci U S A. 2000;97:8536-41.
31. Kleiner DE, Brunt EM, Van Natta M, Behling C, Contos MJ, Cummings OW, Ferrell LD, Liu YC, Torbenson MS, Unalp-Arida A, Yeh M, McCullough AJ, Sanyal AJ; Nonalcoholic Steatohepatitis Clinical Research Network. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology. 2005;41:1313-21.
32. Koteish A, Diehl A. Animal models of steatosis. Semin Liver Dis. 2001;21:89-104.
33. Leclercq IA, Farrell GC, Field J, Bell DR, Gonzalez FJ, Robertson GR. CYP2E1 and CYP4A as microsomal catalysts of lipid peroxides in murine nonalcoholic steatohepatitis. J Clin Invest. 2000;105:1067-75.
34. Leclercq IA. Pathogenesis of steatohepatitis: insights from the study of animal models. Acta Gastroenterol Belg. 2007;70:25-31.
35. London RM, George J. Pathogenesis of NASH: animal models. Clin Liver Dis. 2007;11:55-74.
36. Ludwing J, Viggiano T, McGill D, Oh B. Non-alcoholic steatohepatitis. Mayo Clinic Proc. 1980;55:434-8.
37. Maio R, Dichi JB, Burini RC. Implicações do alcoolismo e da doença hepática crônica sobre o metabolismo de micronutrientes. Arq Gastroenterol. 2000;37:120-4.
38. Martinov MV, Vitvitsky VM, Banerjee R, Ataullakhanov FI. The logic of the hepatic methionine metabolic cycle. Biochim Biophys Acta. 2010;1804:89-96.
39. Misra HP, Fridovich I. The role of superoxide anion in the autoxidation of epinephrine and a simple assay for superoxide dismutase. J Biol Chem. 1972;247:3170-5.
40. Newberne PM, Camargo JLVD, Clark AJ. Choline deficiency, partial hepatectomy and liver tumors in rats and mice. Toxic Pathol. 1982;10:95-106.
41. Palmer M, Schaffener F. Effect of weight reduction on hepatic abnormalities in overweight patients. Gastroenterology. 1990;99:1408-13.
42. Powell EE, Cooksley WG, Hanson R, Searle J, Halliday JW, Powell LW. The natural history of nonalcoholic steatohepatitis: a follow-up study of forty-two patients for up to 21 years. Hepatology. 1990;11:74-80.
43. Rogers A, Newberne P. Alcoholic and nutritional fatty liver and cirrhosis. Am J Pathol 1973;73:817-20.
44. Schann BD. O papel da proteína quinase C no desenvolvimento das complicações vasculares do diabetes mellitus. Arq Bras Endocrinol Metab. 2003;47:654-62.
45. Trimble KC, Molloy AM, Scott JM, Weir DG. The effect of ethanol on one-carbon metabolism: increased methionine catabolism and lipotrope methyl-group wastage. Hepatology. 1993;18:984-9.
46. Vance JE. Secretion of VLDL, but not HDL, by rat hepatocytes is inhibited by the ethanolamine analogue N-monomethylethanolamine. J Lipid Res. 1991;32:1971-82.
47. Varela-Rey M, Embade N, Ariz U, Lu SC, Mato JM, Martínez-Chantar ML. Non-alcoholic steatohepatitis and animal models: understanding the human disease. Int J Bichem Cell Biol. 2009;41:969-76.
48. Weltman MD, Farrell GC, Liddle C. Increased hepatocyte CYP2E1 expression in a rat nutritional model of hepatic steatosis with inflammation. Gastroenterology. 1996;111:1645-53.
49. World Medical Association; American Physiological Society. Guiding principles for research involving animals and human beings. Am J Physiol Regul Integr Comp Physiol. 2002;283:R281-3.
50. Zamin I Jr, Mattos AA, Zettler CG. Non-alcoholic steatohepatitis in nondiabetic obese patients. Can J Gastroenterol. 2002;16:303-7.
51. Zamin I Jr, Mattos AA, Mattos AZ, Migon E, Soares E, Perry ML. Modelo experimental de esteatohepatite não-alcoólica com dieta deficiente em metionina e colina. Arq Gastroenterol. 2009;46:69-74.
52. Zeisel SH, Albright CD, Shin OH, Mar MH, Salganik RI, da Costa KA. Choline deficiency selects for resistance to p53-independent apoptosis and causes tumorigenic transformation of rat hepatocytes. Carcinogenesis. 1997;18:731-8.
53. Zeisel SH. Choline: an essential nutrient for humans. Nutrition. 2000;16:669-71.
54. Zeisel SH, da Costa KA. Choline: an essential nutrient for public health. Nutr Rev. 2009;67:615-23.